[1] WIEST D. Esmolol: a review of its therapeutic efficacy and pharmacokinetic characteristics[J]. Clin Pharmacokinet, 1995, 28(3): 190-202.
[2] 赵慧玲. 盐酸艾司洛尔注射剂有关物质检查的商榷[J]. 药物分析杂志, 2008, 28(9): 1594-1595. doi:  10.16155/j.0254-1793.2008.09.049
[3] MIRAGLIA D, MIGUELL A, ALONSO W. The evolving role of esmolol in management of pre-hospital refractory ventricular fibrillation; a scoping review[J]. Arch Acad Emerg Med, 2020, 8(1): e15. doi:  10.1016/j.ajem.2020.05.083
[4] 肖小武, 程奇珍, 熊蔚, 等. 盐酸艾司洛尔注射液中杂质的分离、合成与结构鉴定[J]. 药物分析杂志, 2011, 31(1): 138-140. doi:  10.16155/j.0254-1793.2011.01.054
[5] LEEY C, ALAMA S, BAASKED M. High-performance liquid chromatographic method for the determination of esmolol hydrochloride[J]. J Pharm Sci, 1984, 73(11): 1660-1661. doi:  10.1002/jps.2600731148
[6] 章为, 蒋涛, 刘雁鸣, 等. 盐酸艾司洛尔注射液的有关物质及其质量评价研究[J]. 中南药学, 2022, 20(11): 2611-2615. doi:  10.7539/j.issn.1672-2981.2022.11.026
[7] HAMEEDAT F, HAWAMDEH S, ALNABULSI S, etal. High performance liquid chromatography(HPLC)with fluorescence detection for quantification of steroids in clinical, pharmaceutical, and environmental samples: areview[J]. Molecules, 2022, 27(6): 1807. doi:  10.3390/molecules27061807
[8] 崔萍, 商少华, 曹庆丰. 高效液相色谱法测定盐酸普萘洛尔中同分异构体杂质β-普萘洛尔的含量[J]. 中南药学, 2024, 22(9): 2415-2419. doi:  10.7539/j.issn.1672-2981.2024.09.026
[9] PAPATHEOCHARIDOU C, SAMANIDOU V. Two-dimensional high-performance liquid chromatography as a powerful tool for bioanalysis: the paradigm of antibiotics[J]. Molecules, 2023, 28(13): 5056. doi:  10.3390/molecules28135056
[10] 国家药典委员会. 中华人民共和国药典二部[S]. 北京: 中国医药科技出版社, 2020: 1063-1064.
[11] 胡昌勤, 张夏. 化学药品杂质谱控制的现状与展望[J]. 药学学报, 2019, 54(12): 2214-2231. doi:  10.16438/j.0513-4870.2019-0451
[12] 敖玲玲. 高效液相色谱法测定盐酸艾司洛尔的含量及有关物质[J]. 中国医药指南, 2013, 11(29): 328-329. doi:  10.3969/j.issn.1671-8194.2013.29.259
[13] 丁洁, 王杰. 高效液相色谱法测定盐酸艾司洛尔及注射液的含量[J]. 药物分析杂志, 1997, 17(3): 191-192. doi:  10.16155/j.0254-1793.1997.03.017
[14] 刘健, 章为. HPLC法测定盐酸艾司洛尔注射液含量的改进[J]. 中国药师, 2018, 21(1): 180-182. doi:  10.3969/j.issn.1008-049X.2018.01.050
[15] United States Pharmacopeial Convention. United States Pharmacopeia-National Formulary [USP 47–NF 42]. Rockville, MD: United States Pharmacopeial Convention; 2024. Esmolol Hydrochloride Injection Monograph.